Suggestions
Amy Burroughs
Amy Burroughs is a seasoned healthcare and life sciences executive with over 25 years of leadership experience.4 She served as President and Chief Executive Officer of Cleave Therapeutics, a clinical-stage company focused on developing novel medicines for oncology and neurodegenerative diseases.3
Burroughs joined Cleave Therapeutics as CEO in August 2019.4 During her tenure, she led the company through financings, spearheaded licensing and collaboration deals, and oversaw the clinical development of its investigational therapy, CB-5339, for the treatment of acute myeloid leukemia.12
Prior to Cleave, Burroughs held several notable positions:
- Executive-in-residence at 5AM Ventures
- Senior advisor to Crinetics Pharmaceuticals during its initial public offering
- Founder and managing partner of The Ventral Group, a strategic life sciences consulting firm
- Commercial Team Leader at Genentech, contributing to successful product launches
- Chief Commercial Officer and head of business development at APT Pharmaceuticals34
Burroughs earned her MBA from Harvard Business School, where she graduated as a Baker Scholar, and her BA in computer science with a minor in economics from Dartmouth College.2
As of February 2024, Burroughs has been appointed as Chief Executive Officer and a member of the Board of Directors at Terns Pharmaceuticals.12
